Fritextsökning
Innehållstyper
-
Så kan ni växa med ett mobilt ERP
Affärssystemet är hjärtat och själva motorn i företaget, det hjälper till att automatisera och hålla ordning på allt från ordrar, inköp, produktion, lager, leve...
-
The route to vaccines for everyone: “We did not just sit around and wait”
The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...
-
Elicera develops CAR-T against solid tumours – may become the first in the world
Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...
-
Ännu ett genterapibolag krisar – säger upp 100
Det är tuffa tider för många cell- och genterapibolag. Det senaste exemplet är amerikanska Bluebird Bio, som säger upp var fjärde anställd i ett försök att rädda verksamheten.
-
Improve your secondary battery manufacturing
SMC provides a large portfolio of products specially designed for secondary battery industry.
-
Läkemedel mot Fabrys sjukdom bedöms för dyra – TLV trycker på stoppknappen
Samtliga läkemedel som används för behandling av enzymbristtillståndet Fabrys sjukdom utesluts ur högkostnadsskyddet.
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...
-
Nässprej för behandling av anafylaxi godkänd i USA
Den amerikanska läkemedelsmyndigheten, FDA, har gett tummen upp till en ny typ av nässprej. Nässprejen är ett injektionsfritt alternativ för behandling av akuta...
-
Pharma-on-Demand
Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...
-
Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages
For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...
-
Effektivisera din produktion med Definox piggingsystem
Vill du optimera din produktion, minska spill och samtidigt göra en lönsam investering? Med Definox piggingsystem, som erbjuds av OEM Automatic, kan du spara bå...
-
Nytt läkemedel mot schizofreni godkänt i USA
För första gången på flera decennier har en ny typ av läkemedel mot schizofreni godkänts av den amerikanska läkemedelsmyndigheten FDA.
-
Giulia Gaudenzi: ”Key lessons from global health research”
The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.
-
Webinar: What is Regulatory Affairs?
This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.
-
The most important Swedish medical innovations: Our ranking
Life Science Sweden turns 20 years old – and celebrates by producing a top list of the 20 most important contemporary Swedish innovations in the field of medicine.
-
A new international stem cell research centre has been created in Copenhagen
A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will adv...
-
Bilden av Alzheimers – neurobiolog vid SU och KI får Lennart Nilssons pris
Med fascinerande bilder och filmer i 3D har han bidragit till ökad kunskap om allt från innerörats anatomi till sjukdomar som fettlever och Alzheimers. Nu tilld...
-
Anna Törner: Success requires bold decisions!
“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.
-
Nya miljardbesparingar på Pfizer
Den amerikanske läkemedelsjätten Pfizer aviserar ett sparprogram som ska sänka bolagets kostnader med 1,5 miljarder dollar, motsvarande 16 miljarder kronor, und...
-
Medical Applications
Video about metrology solutions for medical components
-
Anna Törner: You won’t find this many Concorde projects anywhere else
"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.
-
Stockholm aims at becoming one of the world’s top life science regions
Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 20...
-
We will now publish more news in English – and offer yet another newsletter
Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.